Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.
Dennis SchrijndersGeertruida H de BockSebastiaan T HouwelingKornelis J J van HaterenKlaas H GroenierJeffrey A JohnsonHenk J G BiloNanne KleefstraGijs W D LandmanPublished in: BMC cancer (2017)
Nederlands Trialregister ( NTR6166 ), 6 Jan 2017.